AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 36 filers reported holding AQUESTIVE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 2.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $294,243 | -44.8% | 192,316 | -40.4% | 0.00% | – |
| Q2 2023 | $532,861 | +154352.5% | 322,946 | +6.6% | 0.00% | – |
| Q1 2023 | $345 | +721.4% | 302,848 | +554.4% | 0.00% | – |
| Q4 2022 | $42 | -100.0% | 46,280 | -90.3% | 0.00% | – |
| Q3 2022 | $557,000 | -21.4% | 475,871 | -57.1% | 0.00% | – |
| Q2 2022 | $709,000 | +4.4% | 1,108,764 | +326.2% | 0.00% | – |
| Q1 2022 | $679,000 | -51.4% | 260,180 | -27.5% | 0.00% | -100.0% |
| Q4 2021 | $1,396,000 | -1.1% | 358,875 | +10.8% | 0.00% | 0.0% |
| Q3 2021 | $1,412,000 | -18.8% | 323,774 | -26.1% | 0.00% | 0.0% |
| Q2 2021 | $1,738,000 | +769.0% | 437,854 | +1069.4% | 0.00% | – |
| Q4 2020 | $200,000 | -73.3% | 37,444 | -75.7% | 0.00% | -100.0% |
| Q2 2020 | $749,000 | +44.0% | 154,047 | -35.1% | 0.00% | 0.0% |
| Q1 2020 | $520,000 | -75.3% | 237,394 | -34.4% | 0.00% | -66.7% |
| Q4 2019 | $2,107,000 | +562.6% | 362,016 | +261.7% | 0.00% | +200.0% |
| Q3 2019 | $318,000 | -71.6% | 100,089 | -62.4% | 0.00% | -50.0% |
| Q2 2019 | $1,118,000 | +671.0% | 266,142 | +1056.6% | 0.00% | – |
| Q4 2018 | $145,000 | – | 23,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $16,188,081 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 725,208 | $1,196,593 | 3.78% |
| Bracebridge Capital, LLC | 428,571 | $707,142 | 0.39% |
| Latash Investments, LLC | 243,134 | $401,171 | 0.32% |
| XTX Topco Ltd | 138,145 | $227,939 | 0.04% |
| ARMISTICE CAPITAL, LLC | 1,158,000 | $1,910,700 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 84,355 | $139,186 | 0.01% |
| Hillsdale Investment Management Inc. | 66,600 | $109,890 | 0.01% |
| D.B. Root & Company, LLC | 12,950 | $21,368 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 147,856 | $243,962 | 0.01% |